What can neutralizing antibodies tell us about the quality of immunity in COVID-19 convalescents and vaccinees?
During the SARS-CoV-2 pandemic, the lack of standardized measurements of the immune response after vaccination or recovery from COVID-19 resulted in incomparable results and hindered correlation establishment. Prioritizing reliable and standardized methods to monitor pathogen-specific immunity is cr...
Saved in:
| Main Authors: | Sanda Ravlić, Tihana Kurtović, Lidija Cvetko Krajinović, Ana Hećimović, Marija Miloš, Sanja Mateljak Lukačević, Alemka Markotić, Beata Halassy |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2023-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2023.2270310 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neutralizing antibodies from naturally infected individuals against SARS-CoV-2 Gamma and Delta variants in the Paraguayan population
by: Angélica Samudio, et al.
Published: (2023-10-01) -
Effectiveness of Convalescent Plasma Therapy in Treating COVID-19: an Evidence-based Case Report
by: Mira Yulianti, et al.
Published: (2022-01-01) -
Efficacy and safety of SARS-CoV-2 neutralizing antibody, SCTA01, in high-risk outpatients diagnosed with COVID-19: A Phase II clinical trial
by: Jorge Diaz, et al.
Published: (2025-06-01) -
Functional mapping of B-cell linear epitopes of SARS-CoV-2 in COVID-19 convalescent population
by: Zhigang Yi, et al.
Published: (2020-01-01) -
Lack of cross-neutralization by SARS patient sera towards SARS-CoV-2
by: Danielle E. Anderson, et al.
Published: (2020-01-01)